0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Article |  FREE
Sarah C. Lidstone, PhD; Michael Schulzer, MD, PhD; Katherine Dinelle, MSc; et al.
Arch Gen Psychiatry. 2010;67(8):857-865. doi:10.1001/archgenpsychiatry.2010.88.

Original Article |  FREE
Philipp M. Meyer, MD; Karl Strecker, MD; Kai Kendziorra, MD; et al.
Arch Gen Psychiatry. 2009;66(8):866-877. doi:10.1001/archgenpsychiatry.2009.106.
Includes: Supplemental Content

Original Article |  FREE
Gennarina Arabia, MD, MSc; Brandon R. Grossardt, MS; Yonas E. Geda, MD, MSc; et al.
Arch Gen Psychiatry. 2007;64(12):1385-1392. doi:10.1001/archpsyc.64.12.1385.

Original Article |  FREE
Frank Schneider, MD, PhD; Ute Habel, PhD; Jens Volkmann, MD; et al.
Arch Gen Psychiatry. 2003;60(3):296-302. doi:10.1001/archpsyc.60.3.296.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
Related JAMA Psychiatry Collections
From The JAMA Network
JAMA Neurology
Original Investigation  | 
Frequency of Cholinergic and Caudate Nucleus Dopaminergic Deficits Across the Predemented Cognitive Spectrum of Parkinson Disease and Evidence of Interaction Effects
Nicolaas I. Bohnen, MD, PhD; Roger L. Albin, MD; Martijn L. T. M. Müller, PhD; et al.
JAMA Neurology
Original Investigation  | 
Evolution of Prodromal Clinical Markers of Parkinson Disease in a GBA Mutation–Positive Cohort
Michelle Beavan, MRCP(UK); Alisdair McNeill, PhD, MRCP(UK); Christos Proukakis, PhD, FRCP; et al.
JAMA Internal Medicine
Invited Commentary  | 
Finding Meaningful Patterns in Adverse Drug Event Reports
Joshua J. Gagne, PharmD, ScD
JAMA Internal Medicine
Invited Commentary  | 
Dopamine Receptor Agonist Drugs and Impulse Control Disorders
Howard D. Weiss, MD; Gregory M. Pontone, MD